Shree Pacetronix Quarterly Results for Trading Insights
In Mar 2026, Shree Pacetronix (SHREEPAC) reported revenue ₹5 Cr and net profit ₹1 Cr — revenue +25.0% YoY. Browse SHREEPAC annual financials for revenue, profit, balance sheet and cash flow data.
SHREEPAC Quarterly Results — Revenue, Profit & EPS Highlights
Shree Pacetronix latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit SHREEPAC share price screener.
- Revenue of ₹5 Cr in Mar 2026 (-28.6% vs Sept 2025, +25.0% vs Mar 2025)
- Net Profit of ₹1 Cr in Mar 2026 (+0.0% vs Sept 2025)
- EBITDA of ₹2 Cr in Mar 2026 (+0.0% vs Sept 2025)
- Operating Margin of 30.0% in Mar 2026 (-1.0pp vs Sept 2025)
- Earnings Per Share of ₹3.06 in Mar 2026 (-15.9% vs Sept 2025)
Shree Pacetronix Quarterly Results — Revenue, EBITDA, Net Profit & EPS
SHREEPAC quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 5 | 7 | 4 | 5 | 4 | -28.6% | 25.0% |
| Net Profit (₹ Cr) | 1 | 1 | 0 | 1 | 0 | - | - |
| EBITDA (₹ Cr) | 2 | 2 | 1 | 1 | 0 | - | - |
| EPS (₹) | 3.06 | 3.64 | 1.26 | 1.85 | 0.16 | - | - |
| Operating Margin (%) | 30.0% | 31.0% | 23.0% | 22.0% | 10.0% | - | - |
SHREEPAC Share Price Trend — 1-Year Movement Across Quarterly Results
Shree Pacetronix 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore SHREEPAC share price data to track price trends across different timeframes.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
SHREEPAC vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Shree Pacetronix latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹457,721.13 Cr | 1904.8 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 168.6 |
|
Divis Laboratories
Mar 2026 |
₹174,081.02 Cr | 6757.0 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 238.7 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹161,380.94 Cr | 4768.3 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 414.3 |
|
Cipla
Mar 2026 |
₹117,800.00 Cr | 1458.2 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 212.3 |
|
Zydus Life Science
Mar 2026 |
₹115,505.60 Cr | 1140.6 | 7,569 | 1,341 | +23.1% | +18.8% | 17.7% | 90.2 |
All amounts in ₹ Crores